News

October 8, 2026

SpectaCell raises €6 million to bring better immune therapies to patients faster

SpectaCell develops a fast, label-free single-cell analysis platform that helps biopharma measure how well immune therapies work, from early R&D through manufacturing

October 6, 2026

Spica Therapeutics Appoints Jeff Abbey as CEO

Spica is pioneering Macrophage-Subset targeted therapies

September 10, 2026

Sentea selected by SKF as fibre-optic sensing moves into industrial-scale deployment

Sentea’s integrated fibre-optic sensing platform powers the next generation of SKF Insight bearings

August 11, 2026

Tanai Therapeutics appoints Josua Jordi as Chief Executive Officer

Former CSO and experienced obesity drug discovery executive to lead Tanai as the company advances its small-molecule pipeline

August 10, 2026

Curium acquires Abscint SA

ABSCINT is developing single-domain antibodies for disease diagnosis through imaging.

July 17, 2026

Qbic III provides pre-seed funding to Sightera Biosciences

Sightera is developing a patient-derived AI drug discovery platform

July 6, 2026

MRM Health Strengthens Board

Appointing Michel Detheux as Chairman of the Board and Hans-Jürgen Wörle as Independent Director

June 4, 2026

moveUP and Cascador Health Merge to Build a Data-Driven Digital Health Powerhouse

Providing an end-to-end offering across the product lifecycle

June 2, 2026

ABSCINT announced compelling clinical results for HER2-targeted imaging

ABSCINT is developing single-domain antibodies for disease diagnosis through imaging.

May 29, 2026

MRM Health awarded € 2.6M VLAIO Research Grant

Accelerating the development of novel therapeutics that redefine the treatment of immune mediated inflammatory diseases

May 11, 2026

eyeo raises €40 million Series A

eyeo develops breakthrough color-splitting photonics for ultra-compact, high-performance imaging

May 4, 2026

MRM Health Granted FDA FAST Track designation for MH002

Recognizing the potential of MRM Health's Lead Candidate to address a serious medical condition with high unmet need

December 2, 2025

AILOS Robotics raises €3.5 million in Seed Funding

AILOS is redefining actuation for next generation robotics

November 28, 2025

Qbic III provides pre-seed funding to Innocens

Innocens helps clinicians make faster, smarter decisions with AI-powered alerts for patient deterioration.

November 27, 2025

Obulytix Strengthens Senior Leadership with Key Executive and Board Appointments

Obulytix develops the next generation of enzyme-based antibiotics inspired by nature.

September 4, 2025

MRM Health Raises €55 Million Series B

Supporting confirmatory Phase 2 trial with MRM Health’s lead program and advance two additional programs to IND approval

August 28, 2025

VoxelSensors announces collaboration with Qualcomm Technologies

VoxelSensors is developing ultra-low power and ultra-low latency 3D perception sensors for Extended Reality.

August 27, 2025

Citymesh partners with Accelleran to deploy commercial-grade 5G small cells in urban areas

Accelleran is a global leader in 4G/5G Cloud-Native OpenRAN platforms.

August 27, 2025

Spica Therapeutics secures € 1 Million VLAIO Grant to advance macrophage-targeted therapies

Spica is pioneering Macrophage-Subset targeted therapies

July 1, 2025

Animab Secures EUR 10 Million in Series B Financing

Supporting commercialization of Nanoprotec® in Europe

June 25, 2025

Swave Photonics raises additional €6M Series A Funding from IAG Capital Partners and Samsung Ventures

Swave develops holographic eXtended reality technology to make virtual reality practically indistinguishable from the real world.

June 3, 2025

Spica Therapeutics closes € 10 Million seed round to advance macrophage-targeted therapies

Spica is pioneering Macrophage-Subset targeted therapies

May 12, 2025

Blue Foot Membranes appoints Carlos Campos as Chairman of the Board

Passing the torch – A new chapter at Blue Foot

May 7, 2025

Eyeo raises €15 million seed round to give cameras perfect eyesight

eyeo develops breakthrough color-splitting photonics for ultra-compact, high-performance imaging

April 29, 2025

Qbic III provides pre-seed funding to Rainbow Crops

VIB launches new Agtech spin-off Rainbow Crops to develop climate-resilient crop varieties

April 22, 2025

Animab enters into an exclusive distribution agreement with Huvepharma

Commercializing Nanoprotec® for ETEC protection in piglets in Europe

March 13, 2025

moveUP to acquire Deep Structure.ai, strengthening AI-Driven Orthopedic Care

moveUP develops personalized remote digital care for patients undergoing surgery and other interventions.

March 11, 2025

Aloxy raises €7.4 million from Dow Venture Capital, Emerson Ventures and existing investors to accelerate its global expansion

Aloxy offers reliable IIot solutions tailored to the needs of the process industry.

January 30, 2025

Qbic III provides pre-seed funding to Pleevi

Pleevi makes workplace charging smarter, greener and more cost-efficient

January 22, 2025

Tanai Therapeutics appoints Pieter Rottiers as Chief Executive Officer

A seasoned Chief Executive, with over 20 years of distinguished leadership in medical biotechnology

January 3, 2025

Swave Photonics raises €27M Series A Funding for the introduction of dynamic 3D holographic display products

Swave develops holographic eXtended reality technology to make virtual reality practically indistinguishable from the real world.

December 9, 2024

QustomDot secures EUR 2.7 million in financing to propel innovation and market growth

QustomDot is developing cadmium-free quantum dots that are stable enough for advanced applications.

October 9, 2024

Belgian Health Data Company Cascador Health aims for European leadership with strategic acquisitions in immunology and neurology

Cascador Health bridges the gap between data sources and the users of healthcare data.

October 1, 2024

Obulytix appoints Dr. Kristof Van Emelen as Chief Executive Officer

Obulytix develops the next generation of enzyme-based antibiotics inspired by nature.

September 19, 2024

Tanai Therapeutics secures additional financing from Novo Nordisk and BioGeneration Ventures for novel obesity drug

Strong investor syndicate and renowned board of scientific experts demonstrate the high potential of Tanai’s innovative approach

September 10, 2024

MRM Health appoints Grégoire Franoux as Chief Business Officer and adds Ron Robison to its Board of Directors

MRM Health is developing a novel type of therapeutics based on beneficial intestinal bacteria.

August 28, 2024

Weavely raises €900K seed round to build interactive content with AI

Weavely develops a no-code platform that generates interactive content from digital designs.

July 5, 2024

Blue Foot Membranes completes €15 Million Funding Round and appoints Carlos Campos as Independent Director

Blue Foot provides water-intensive industries with the technology to reuse water.

May 22, 2024

Animab announces Jan Spaas as new Chairman of the Board

Veterinary therapeutics company Animab welcomes new Chairman of the Board.

April 24, 2024

Flindr raises €20 million in Series A

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

April 18, 2024

AmphiStar raises €6 million in Seed funding

AmphiStar secures €6 million to launch eco-friendly and cost-effective biosurfactants derived from waste

February 7, 2024

Blue Foot Membranes raises €10 million round

Blue Foot provides water-intensive industries with the technology to reuse water.

February 7, 2024

VoxelSensors raises an additional €3 Million in Seed Extension

VoxelSensors is developing ultra-low power and ultra-low latency 3D perception sensors for Extended Reality.

December 6, 2023

Tanai Therapeutics raises € 2.85 million round in Seed funding

New VIB spinoff Tanai Therapeutics develops first-in-class therapeutics for obesity

October 24, 2023

Obulytix raises € 4 million round in Seed funding

Obulytix is developing a revolutionary solution for antibiotic resistance

September 26, 2023

ABSCINT raises € 3 million round to initiate Phase II Clinical Trials

ABSCINT is developing single-domain antibodies for disease diagnosis through imaging.

September 5, 2023

Axithra raises € 10 million in Seed funding

Developing new technology for accurate drug concentrations in blood.

July 11, 2023

Aphea.bio raises a € 70 million Series C round

Aphea.Bio is developing the next generation of agricultural biologicals.

July 7, 2023

Final closing brings Qbic III to 88.5 million euros

Qbic III increases capital to 88.5 million euros to invest in spin-off companies of Belgian world-renowned knowledge institutions.

May 26, 2023

Qbic III co-leads VoxelSensors' Seed round

VoxelSensors is developing ultra-low power and ultra-low latency 3D perception sensors for Extended Reality.

January 17, 2023

Qbic looking to strengthen its team

Qbic is looking to strengthen its team with an Investment Analyst

January 4, 2023

Indigo Diabetes Business Update

Indigo is developing an implantable sensor that allows to continuously measure glucose and other metabolites for up to two years.

December 5, 2022

ABSCINT raises new financing round

ABSCINT is developing single-domain antibodies for disease diagnosis through imaging.

November 9, 2022

Qbic III leads Animab's Series A round

Animab develops antibodies to tackle gastrointestinal pathogens in livestock.

October 27, 2022

Indigo expands in the US and appoints Peter Devlin as President Indigo Medical US Inc.

Indigo is developing an implantable sensor that allows to continuously measure glucose and other metabolites for up to two years.

September 27, 2022

Qbic III provides pre-seed funding to weave.ly

Weave.ly is developing a pioneering no-code platform that allows for partial automation of the software development process.

September 5, 2022

Qbic III leads THERAtRAME's Seed round

THERAtRAME develops and positions new therapeutics targeting tRNA epitranscriptomics in cancer.

June 28, 2022

Qbic III invests in Swave

Swave develops holographic eXtended reality technology to make virtual reality practically indistinguishable from the real world.

June 16, 2022

Aloxy raises € 3.8M funding round

Aloxy offers reliable IIot solutions tailored to the needs of the process industry.

March 25, 2022

Qbic II leads Cascador Health's Series A round

Cascador Health bridges the gap between data sources and the users of healthcare data.

March 16, 2022

Qbic establishes third fund

Qbic announces first close of new fund at € 49 million to invest in spin-offs from world-class knowledge partners.

December 23, 2021

EyeD Pharma raises € 32M funding round

EyeD Pharma is developing micro-implants for drug release over a prolonged period of time.

December 21, 2021

Biogazelle acquired by CellCarta

Biogazelle develops and deploys high-end digital PCR, quantitative PCR and RNASeq assays.

December 2, 2021

Trince raises € 4M with support of Qbic II

Trince developed a new transfection technology based on a combination of laser light and photothermal nanoparticles.

November 22, 2021

Molecubes acquired by Bruker

Molecubes builds preclinical imaging cubes, allowing SPECT, PET and CT imaging in almost any lab space.

November 8, 2021

PharmaFluidics acquired by Thermo Fisher Scientific

PharmaFluidics developed a complementary range of reversed-phase chromatography columns for systems biology and biopharma applications.

October 7, 2021

Sentea raises € 2.3M to further grow its business

Sentea leverages silicon photonics to develop a cost-effective fiber optic sensor interrogator.

June 22, 2021

Qbic II leads CrowdScan's Series A round

CrowdScan provides accurate and privacy-friendly crowd measurement data.

June 17, 2021

moveUP secures € 3.65M in financing round

moveUP develops data-driven personalized remote digital care for patients undergoing surgery and other interventions.

May 18, 2021

Qbic II leads seed round in Abscint

ABSCINT focuses on diagnostics based on single domain antibodies.

May 18, 2021

Indigo Diabetes Initiates First Clinical Study

Indigo is pioneering an invisible glucose sensor for people living with diabetes.

May 18, 2021

Aphea.bio closes its Series B round and raises € 18M in total

Aphea.Bio is developing the next generation of agricultural biologicals.

February 16, 2021

Accelleran raises € 6.8M with support of Qbic II

Accelleran is a global leader in 4G/5G Cloud-Native OpenRAN platforms.

SpectaCell raises €6 million to bring better immune therapies to patients faster

Spica Therapeutics Appoints Jeff Abbey as CEO

Sentea selected by SKF as fibre-optic sensing moves into industrial-scale deployment

Tanai Therapeutics appoints Josua Jordi as Chief Executive Officer

Curium acquires Abscint SA

Qbic III provides pre-seed funding to Sightera Biosciences

MRM Health Strengthens Board

moveUP and Cascador Health Merge to Build a Data-Driven Digital Health Powerhouse

ABSCINT announced compelling clinical results for HER2-targeted imaging

MRM Health awarded € 2.6M VLAIO Research Grant

eyeo raises €40 million Series A

MRM Health Granted FDA FAST Track designation for MH002

AILOS Robotics raises €3.5 million in Seed Funding

Qbic III provides pre-seed funding to Innocens

Obulytix Strengthens Senior Leadership with Key Executive and Board Appointments

MRM Health Raises €55 Million Series B

VoxelSensors announces collaboration with Qualcomm Technologies

Citymesh partners with Accelleran to deploy commercial-grade 5G small cells in urban areas

Spica Therapeutics secures € 1 Million VLAIO Grant to advance macrophage-targeted therapies

Animab Secures EUR 10 Million in Series B Financing

Swave Photonics raises additional €6M Series A Funding from IAG Capital Partners and Samsung Ventures

Spica Therapeutics closes € 10 Million seed round to advance macrophage-targeted therapies

Blue Foot Membranes appoints Carlos Campos as Chairman of the Board

Eyeo raises €15 million seed round to give cameras perfect eyesight

Qbic III provides pre-seed funding to Rainbow Crops

Animab enters into an exclusive distribution agreement with Huvepharma

moveUP to acquire Deep Structure.ai, strengthening AI-Driven Orthopedic Care

Aloxy raises €7.4 million from Dow Venture Capital, Emerson Ventures and existing investors to accelerate its global expansion

Qbic III provides pre-seed funding to Pleevi

Tanai Therapeutics appoints Pieter Rottiers as Chief Executive Officer

Swave Photonics raises €27M Series A Funding for the introduction of dynamic 3D holographic display products

QustomDot secures EUR 2.7 million in financing to propel innovation and market growth

Belgian Health Data Company Cascador Health aims for European leadership with strategic acquisitions in immunology and neurology

Obulytix appoints Dr. Kristof Van Emelen as Chief Executive Officer

Tanai Therapeutics secures additional financing from Novo Nordisk and BioGeneration Ventures for novel obesity drug

MRM Health appoints Grégoire Franoux as Chief Business Officer and adds Ron Robison to its Board of Directors

Weavely raises €900K seed round to build interactive content with AI

Blue Foot Membranes completes €15 Million Funding Round and appoints Carlos Campos as Independent Director

Animab announces Jan Spaas as new Chairman of the Board

Flindr raises €20 million in Series A

AmphiStar raises €6 million in Seed funding

Blue Foot Membranes raises €10 million round

VoxelSensors raises an additional €3 Million in Seed Extension

Tanai Therapeutics raises € 2.85 million round in Seed funding

Obulytix raises € 4 million round in Seed funding

ABSCINT raises € 3 million round to initiate Phase II Clinical Trials

Axithra raises € 10 million in Seed funding

Aphea.bio raises a € 70 million Series C round

Final closing brings Qbic III to 88.5 million euros

Qbic III co-leads VoxelSensors' Seed round

Qbic looking to strengthen its team

Indigo Diabetes Business Update

ABSCINT raises new financing round

Qbic III leads Animab's Series A round

Indigo expands in the US and appoints Peter Devlin as President Indigo Medical US Inc.

Qbic III provides pre-seed funding to weave.ly

Qbic III leads THERAtRAME's Seed round

Qbic III invests in Swave

Aloxy raises € 3.8M funding round

Qbic II leads Cascador Health's Series A round

Qbic establishes third fund

EyeD Pharma raises € 32M funding round

Biogazelle acquired by CellCarta

Trince raises € 4M with support of Qbic II

Molecubes acquired by Bruker

PharmaFluidics acquired by Thermo Fisher Scientific

Sentea raises € 2.3M to further grow its business

Qbic II leads CrowdScan's Series A round

moveUP secures € 3.65M in financing round

Qbic II leads seed round in Abscint

Indigo Diabetes Initiates First Clinical Study

Aphea.bio closes its Series B round and raises € 18M in total

Accelleran raises € 6.8M with support of Qbic II

Contact us

Find us

More